We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015

By Paul Mills
Posted on 24 May 2016
A breakthrough technology now enables the manufacture of plastic exterior components with complete interior coverage of pure glass. More...
Attendees of the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA) are invited to visit Booth 3615 to learn about how the broad range of products envisioned from the application of this technology could provide numerous benefits, including for clinical science.

“This breakthrough will allow us to provide products that have the best of both worlds: the lightweight, break resistant properties of plastic with the barrier qualities and inert inner surface of pure glass,” said Wayne Brinster, president and CEO of Wheaton (Millville, NJ, USA), a leading provider of innovative plastic- and glass-based solutions for research, diagnostic, and specialty pharmaceutical industries. “For 126 years Wheaton has been an innovator in glass as well as plastic for laboratories. Customers look to us to solve their needs and this technology will allow us to develop purpose-built products that blend the features of both glass and plastic into a single innovative solution,” he added.

The technology is broadly applicable across the bulk of the company’s product range. Benefits of a pure glass interior include the elimination of compounds from the container contaminating the contents as occasionally occurs with plastic products, while also providing an interior surface with less vapor transmission and higher resistance to solvents. This is combined with the benefit of the lightweight plastic exterior protecting the glass from cracking and breakage.

“We understand that there are many applications where using a plastic product or a glass product are appropriate,” said Mr. Brinster, “But we also know that there are applications where having both materials in one product has long been needed. These premium products will fill those needs as none have been available until now. The tooling needed for broad production of the glass and plastic products is being built now and we expect to begin delivery of these products to customers in the fourth quarter this year.”

Related Links:

Wheaton
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.